CIK 0001728117
- Non-accelerated filer
- Smaller reporting company
Gossamer Bio, Inc.
Sign in to watch- Ticker
- GOSS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475461709
- Phone
- +1 858-684-1300
- Business address
- 3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 6 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-20 | Carter Laura Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +157,500 | 157,500 | ||
| 2023-03-16 | Carter Laura Chief Scientific Officer | Sale | −6,029 | $1.10 | $7K | 76,263 |
| 2022-12-07 | Carter Laura Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +157,500 | 157,500 | ||
| 2022-10-24 | Carter Laura Chief Scientific Officer | Sale | −4,876 | $12.07 | $59K | 82,292 |
| 2022-10-24 | Carter Laura Chief Scientific Officer | Sale | −4,876 | $12.07 | $59K | 82,292 |
| 2022-07-15 | Carter Laura Chief Scientific Officer | Purchase | +6,934 | $7.21 | $50K | 87,168 |
| 2022-07-01 | Carter Laura Chief Scientific Officer | Sale | −8,808 | $8.25 | $73K | 80,234 |
| 2022-05-04 | Carter Laura Chief Scientific Officer | Sale | −1,262 | $7.20 | $9K | 89,042 |
| 2022-03-16 | Carter Laura Chief Scientific Officer | Sale | −5,002 | $8.28 | $41K | 90,304 |
| 2022-01-06 | Carter Laura Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2021-10-25 | Carter Laura Chief Scientific Officer | Sale | −2,377 | $12.25 | $29K | 95,306 |
| 2021-06-30 | Carter Laura Chief Scientific Officer | Grant or award | +25,000 | 97,683 | ||
| 2021-05-03 | Carter Laura Chief Scientific Officer | Grant or award | +10,820 | 72,683 | ||
| 2021-05-03 | Carter Laura Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +31,750 | 31,750 |
Page 1 of 1 · 14 trades